A B S T R A C T It is well established that viral infections may precipitate or worsen attacks of bronchial asthma. Furthermore, in symptomatic atopic subjects, the local accumulation of basophils and the production ofa basophil chemotactic factor have been reported. We have investigated the effect ofcell-free supernates from viral stimulated cultures of human mononuclear cells on the in vitro migration of human basophils. Our results show the presence of a factor in these culture supernates that enhances the migration of basophils toward two separate chemoattractants, a peptide from C5 and a lymphokine. The enhancing activity, while affecting basophil migration, did not change the response of monocytes.
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The enhancing activity resembled viral-induced interferon when (a) pH 2 stability, (b) heat resistance, (c) trypsin sensitivity, and (d) species-specificity were compared. Finally, the enhancing activity for basophil chemotaxis and the interferon titer were highly correlated in preparations with a 104-fold difference in interferon specific activity.
Our studies show that viral-induced interferon can augment the in vitro chemotactic response ofbasophils. Because mediators present in basophils may be involved in the pathogenesis of immediate hypersensitivity, the modulation of basophil movement by interferon suggests a possible mechanism for the association between viral infections and atopic disorders. INTRODUCTION Viral upper respiratory infections have been shown to trigger recurrent episodes ofwheezing in the asthmatic child (1) (2) (3) (4) (5) . In addition, viral infections can increase bronchial sensitivity to drugs such as methacholine (6) (7) (8) . Histamine, slow reacting substance of anaphylaxis, and eosinophil chemotactic factors, present in tissue mast cells and peripheral blood basophils, are probable contributors to the pathophysiology of atopic diseases (9). It is not clear at present whether basophils play a causative role in asthmatic attacks. However, their participation is suggested by the findings of Kimura et al. (10, 11) who showed that circulating basophils increase in number during the preattack stage of bronchial asthma and fall during attacks with a concomitant rise in the number of basophils in the sputum of patients.
Recently, Ida et al. (12) have suggested that interferon may be a contributing factor in immediate hypersensitivity reactions. They showed that culture of human leukocytes with virus enhances allergen-mediated release of histamine from basophils. The effect was caused by a soluble factor that had many of the properties of interferon. In the present study, we report the enhancement of in vitro basophil migration following incubation of leukocytes with viral-induced human leukocyte interferon. METHODS Virus preparation. Parainfluenza virus type 1 (Sendai) was propagated and assayed by inoculation of the allantoic fluid of embryonating hen's eggs (12) . A purified viral pool containing a titer of 109 5 egg infectious doses., per ml before ultraviolet inactivation was used throughout the study (12) . An influenza subunit vaccine was purchased from Parke-Davis (Morris Plains, N. J.).
Interferon. Human leukocyte interferon (G-023-901-527), human fibroblast interferon (G-023-902-527), and mouse in-terferon (G-002-904-511) were obtained from the Research Resources Branch, National Institute of Allergy and Infectious Diseases. Partially purified human leukocyte interferon was a gift from Dr. K. Paucker, Medical College of Pennsylvania and Hospital. The interferon was induced by Sendai virus according to the method of Cantell, partially purified by antibody affinity chromatography to a specific activity of 2 x 107 U/mg protein (13) and stabilized in 0.5% bovine serum albumin (BSA,' fraction V, Sigma Chemical Co., St. Louis, Mo.).
Interferon assay. Interferon was assayed in a microtiter system on human WISH cells using Sindbis virus (14, 15 Chemotactic factors. A C5 peptide(s) with chemotactic activity was partially purified by Sephadex G-75 chromatography ofzymosan-activated fresh human serum as previously described (17) . Lymphocyte-derived chemotactic factor (LDCF) was prepared by stimulating human leukocytes with streptokinase-streptodornase (SKSD, Varidase, Lederle Laboratories, Pearl River, N. Y.) and partially purified by Ultrogel ACA-44 chromatography as previously reported (18) .
Preincubations. Fresh basophil-enriched mononuclear cells, prepared as above, were resuspended at 10-15 x 106 cells/ml in RPMI 1640 and incubated for 1 h at 37°C with an equal volume ofstimulated supemate. The cells were washed, resuspended at 10-15 x 106 cells/ml in Gey's balanced salt solution (Gibco Laboratories) containing 2% BSA, and assayed for chemotactic response.
Measurement of migration. Chemotaxis was measured as previously described (19) in blind well chambers (Neuro Probe, Inc., Bethesda, Md.). The lower compartment, to which 0.2 ml of chemotactic factor solution was added, was separated from the upper compartment by a 10-,um thick polycarbonate filter with 5-).m Diam pores (Neuro Probe, Inc.).
A volume of 0.3 ml of cell suspension (10-15 x 10 cells/ml) was added to the upper compartment. Chambers were incubated for 90 min at 370C. Filters were removed and stained in Wright's stain (20) . Slides were coded and migrated basophils were counted blind in 25-50 randomly selected oil immersion fields (1,250x 
RESULTS
Effect of supernatant fluids on basophil migration. Basophil-enriched mononuclear cells were incubated for 1 h in supernates from leukocytes cultured for 24 h in (a) medium alone, (b) medium with allantoic fluid reconstituted with virus at the end of culture (control), and (c) medium with Sendai virus. Basophils from all donors showed an enhanced response to C5 peptide and LDCF following exposure to supernatant fluids from leukocyte cultures stimulated with virus ( Fig. 1 , P < 0.01, paired t test). The enhancement was seen, irrespective ofwhether the supernates were tested with homologous or autologous basophil-enriched mononuclear cells. Secondly, as shown in Fig. 2 , the enhancement was seen over a fourfold concentration range of chemotactic factors (P < 0.01, by analysis of variance). The response ofbasophils to diluent alone (Gey's -2% BSA) was not affected.
Viral stimulated supernates enhanced the response ofbasophils, but had no effect on the migration ofmonocytes (Table I) in the same chemotactic assay.
Relationship between basophil migration and interferon activity. Since viral stimulated culture supernatants augmented basophil migration and since viralinduced interferon (IFN) has been shown to enhance IgE-mediated histamine release (12) , it was important to consider whether interferon was the active agent in our study. Preliminary results showed that under our conditions of culture all supernates from leukocytes stimulated with virus contained both enhancing activity (1.5 to 2.1 times greater than control) and IFN ( control supernates contained neither IFN nor enhancing activity. Furthermore, Fig. 3 illustrates the effect of reference leukocyte IFN. In all cases, the IFN preparation enhanced the migration of basophils to C5 peptide (P < 0.01, paired t test). Physicochemical properties. To see if the IFN titer could be dissociated from the enhancing activity, viral-stimulated culture fluids were exposed to: (a) pH 2, (b) heat, or (c) trypsin. Table II shows that trypsin essentially destroyed both activities, heat caused a small reduction in both activities, and treatment at pH 2 failed to affect either activity. Effect of mouse interferon. Since the response to viral IFN is usually species specific (13, 21, 22) , the effect of mouse IFN on human basophil migration was examined. Mouse IFN had no enhancing activity at a titer of 2,000 U/ml while human leukocyte IFN increased basophil migration at a titer of 250 U/ml (Table  III) . Furthermore, human fibroblast IFN was as effective as viral-induced leukocyte IFN.
Partially purified interferon. Since the reference leukocyte IFN preparations may contain other soluble products of biological significance, we tested the enhancing activity of an enriched IFN preparation. Fig. 4 compares the enhancing activity and IFN titer of (a) preparation had a specific activity of 2 x 107 U/mg protein (13) . Since the specific activity ofthe interferon preparations varied by a factor of 104, these results clearly support the notion that the enhancing activity is mediated by interferon.
DISCUSSION
The present study shows that preincubation of human basophil-enriched mononuclear cells with supernates from leukocytes cultured with virus enhanced the migration of basophils toward chemotaxins (LDCF and C5-peptide). This effect is specific in that the chemotactic response of basophils was affected while that of monocytes remained unchanged. Moreover, random migration of basophils was not increased.
Several lines of evidence indicate that the enhancing activity is mediated by interferon. All preparations of human IFN, whether leukocyte or fibroblast derived, cause enhancement. The soluble factor causing enhancement cannot be dissociated from IFN by standard physicochemical means (13, 22) and is species specific (21) . Anti-interferon globulin neutralized the antiviral effect of interferon and blocked the enhancing activity (data not shown). The strongest evidence, illustrated in Fig. 4 , is the correlation between enhancing activity and IFN titer when a partially purified preparation of IFN (specific activity = 2 x 107 U/mg protein) was compared to two leukocyte culture supernates (stimulated by either Sendai virus or influenza vaccine, specific activity = 103 U/mg protein). Thus, although the degree of purity varied by a factor of 104, plots of IFN titer vs. enhancing activity were superimposable for the three preparations.
Our interest in the effect of IFN on basophil migration was stimulated by the report of Ida et al. (12) that IFN enhances the degranulation of human basophils and the subsequent release of histamine. While the enhancement of IgE-mediated release of histamine by IFN requires an induction period of 6-9 h and RNA synthesis (23) , in our assay the effect of IFN was rapid. Preincubation with IFN for only 1 h was sufficient to increase the chemotactic response of basophils; moreover, preliminary results show that enhancement can be achieved by adding high concentrations of IFN (2,000 U/ml) to basophils and measuring the chemotactic response immediately afterwards (data not shown). Several other non-antiviral activities have been attributed to interferon, which also occur rapidly. Blalock and Stanton (24) (36, 37) . Since interferon does not have chemotactic activity or affect random migration of basophils, we would not expect basophils to accumulate in nasal passages during viral respiratory infections. Indeed, Hastie et al. (38) observed basophils in the nasal secretions of patients with allergic rhinitis, but not of subjects with viral respiratory infections. Recently, Hirsch and Kalbfleisch (39) found that serum from persons with symptomatic allergic rhinitis contained a basophil chemotactic factor.
Asthma is another clinical problem that involves (at least in some patients) the release of mediators by allergic stimuli. Viral infections are known to precipitate and aggravate asthmatic attacks (4, 5) . Studies in vitro show that IFN will enhance both basophil chemotaxis and the IgE-mediated release of histamine (12, 23, 40) . Moreover, IFN has been shown to modulate various immune responses both in vitro and in vivo (41) . While the exact role of IFN in allergic reactions in man is not known, IFN has been demonstrated in the circulation of patients with autoimmune and allergic diseases (42, 43) . It is reasonable to suggest that any stimulus which would normally induce accumulation and/or degranulation of basophils and mast cells may result in a more severe reaction when interferon is present. In addition, a normally sub-threshold stimulus may induce a reaction during a viral infection. The possibility that IFN may augment chemotaxis of basophils and enhance mediator release in vivo during allergic diseases in man merits further study.
